TODD CARPENTER: Open Payments
NPI 1255629267 · CLARKSTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 28 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $934 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $283 |
| GENZYME CORPORATION | 4 | $106 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| CSL Behring | 3 | $72 |
| Amgen Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| BioCryst US Sales Co., LLC | 1 | $24 |
| Grifols USA, LLC | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| Baxter Healthcare | 1 | $20 |
Products named: TEZSPIRE, DUPIXENT, NUCALA, Andembry, AYVAKIT, ORLADEYO, Prolastin-C Liquid, YUPELRI.
Industry payments across WA — which companies pay providers there.
